# Toll-like Receptor 2 Gene Polymorphism, Serum Cytokines and Susceptibility to Disease Severity or Treatment Response of Pulmonary Tuberculosis

> **NCT00772408** · — · COMPLETED · sponsor: **Chang Gung Memorial Hospital** · enrollment: 300 (actual)

## Conditions studied

- Pulmonary Tuberculosis
- Genetic Variants of Host
- Immune Response of Host

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00772408
- **Lead sponsor:** Chang Gung Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-08
- **Primary completion:** 2009-11
- **Final completion:** 2009-11
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2013-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00772408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00772408, "Toll-like Receptor 2 Gene Polymorphism, Serum Cytokines and Susceptibility to Disease Severity or Treatment Response of Pulmonary Tuberculosis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00772408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*